Live Breaking News & Updates on Trans Urethral Resection

Stay updated with breaking news from Trans urethral resection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

High Wycombe woman reveals terrifying cancer battle after misdiagnosis

A High Wycombe gym instructor was diagnosed said she “cried for two days” after finding out she had bladder cancer – and that it had already… ....

United Kingdom , David Lloyd Beaconsfield , Trans Urethral Resection , Bladder Tumour , Fight Bladder , Lloyd Beaconsfield , Bladder Cancer ,

New Drug Combats Late-stage Prostate Cancer


New Drug Combats Late-stage Prostate Cancer
by Angela Mohan on 
July 12, 2021 at 11:18 AM
New treatment combats late stage prostate cancer by delivering beta radiation directly to tumour cells. It is well tolerated by patients and keeps them alive for longer compared to standard care, as per the phase 3 trial findings.
New approach, targets a molecule called PSMA, which is known to be increased on the surfaces of the tumour cells, destroying them and their surrounding microenvironment.
International team of researchers set out to see whether Lu-PSMA-617 was more effective than standard care and recruited 831 patients with metastatic castration-resistant prostate cancer between June 2018 and October 2019. Patients were randomized to receive the treatment plus standard care or standard care alone. ....

Toxicityprostate Cancercancer , Factscancer Factscancertattoos , Peter Albers , Ken Herrmann , National Institute For Health , Scientific Office , Head Of The Department Urology , Dusseldorf University , Johann De Bono , National Institute , Care Excellence , Professor Peter Albers , Homeopathyclinical Trials , Trans Urethral Resection , பீட்டர் ஆல்பர்ஸ் , கேன் ஹெர்மன் , தேசிய நிறுவனம் க்கு ஆரோக்கியம் , அறிவியல் அலுவலகம் , தலை ஆஃப் தி துறை சிறுநீரகம் , ஜோஹான் டி போனோ , தேசிய நிறுவனம் , பராமரிப்பு சிறப்பானது ,

Asieris and Photocure Expand Strategic Partnership to Bladder Cancer Diagnosis and Surgery in Mainland China and Taiwan


Press release content from PR Newswire. The AP news staff was not involved in its creation.
Asieris and Photocure Expand Strategic Partnership to Bladder Cancer Diagnosis and Surgery in Mainland China and Taiwan
January 26, 2021 GMT
SHANGHAI, Jan. 26, 2021 /PRNewswire/ Asieris Pharmaceuticals announced today that the company has entered into a license agreement with Photocure ASA (Photocure, PHO: OSE) to exclusively register and commercialize Hexvix® in Mainland China and Taiwan. Hexvix® is a drug that preferentially accumulates in bladder cancer cells, making them glow bright pink during Blue Light Cystoscopy (BLC®). It is expected to meet a strong unmet need in the diagnosis and resection of non-muscle invasive bladder cancer (NMIBC) in Mainland China and Taiwan. ....

United Kingdom , United States , City Of , Dan Schneider , Prnewswire Asieris Pharmaceuticals , Bladder Cancer Company , Oslo Stock Exchange , Mainland China , Blue Light Cystoscopy , Taizhou City , Jiangsu Province , Non Muscle Invasive Bladder Cancer , Trans Urethral Resection , Bladder Tumors , Corporate News , Greater China , Pr Newswire , East Asia , Bladder Cancer , Diseases And Conditions , Diagnosis And Treatment , Contracts And Orders , Surgical Procedures , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , நகரம் ஆஃப் ,